Delivery Order SPE2DB22D1106-SPE2DB24FFLC0

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,574.56, is a Firm Fixed Price Delivery Order for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies. The contract, valued at $2,100.90, was awarded by the Defense Logistics Agency (DLA) with a completion date of March 18, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $1,789.07 firm fixed price delivery order is for 4563830856, described as OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, to be delivered by March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The award, with a ceiling value of $1,400.60, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 6, 2025. This award is not designated as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,017.45, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 21, 2024. The award was made on February 20, 2024, and there was no set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,242.80, is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the pharmaceutical product OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $3,559.44 and has an Ultimate Completion Date of November 20, 2024. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
The federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies, with a ceiling value of $3,501.50. The contract was awarded on June 6, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 9, 2025 and is a firm fixed-price delivery order. The contract is not set-aside and is an open competition....
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,839.00 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, with a completion date of June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,775.15 firm fixed price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product, with an ultimate completion date of November 1, 2024. AmerisourceBergen holds two relevant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFLC0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,819.58 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a prescription medication. The contract has an ultimate completion date of September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/5/24, 9:03 AM